Answers are grounded in this paper and cite their sources.
Demonstrates potent antimicrobial and anticancer activities in synthesized compounds, indicating dual therapeutic potential.
The development of novel antimicrobial and anticancer agents remains a priority due to rising drug resistance and high systemic toxicity of current treatments. A series of novel pyrazole ( 2–6 ), pyrimidine ( 7–10 ), and pyridine/oxazinone ( 11–14 ) derivatives were synthesized from a chalcone scaffold ( 1 ). They were evaluated for antimicrobial, antibiofilm ( Pseudomonas aeruginosa ), and cytotoxic (HepG2 cells) activities. Molecular docking and qRT-PCR were performed to study their mechanism. Pyrazoles 3–5 and oxazinone 13 showed potent antibacterial activity against S. aureus (MIC = 2–3.12 µg/mL). Compounds 4 and 13 effectively eradicated P. aeruginosa biofilms, achieving a ≥ 5 log 10 reduction within 4 h at 0.8 × MIC, driven by disruption of the bacterial respiratory chain. For anticancer activity, compounds 10 and 13 selectively reduced HepG2 cell viability to 35–40% via oxidative stress-mediated apoptosis. Mechanistically, compound 4 reduced gyrB expression in E. coli by approximately 4.6-fold, while molecular docking supported its interaction with the ATP-binding pocket of DNA gyrase. Overall, the functionalized heterocycles, particularly compounds 4 and 13 , represent promising dual-acting candidates with potent antibacterial, antibiofilm, and selective anticancer activities.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: